CAG repeat length in RAI1 is associated with age at onset variability in spinocerebellar ataxia type 2 (SCA2)

S Hayes, G Turecki, K Brisebois… - Human molecular …, 2000 - academic.oup.com
S Hayes, G Turecki, K Brisebois, I Lopes-Cendes, C Gaspar, O Riess, LPW Ranum
Human molecular genetics, 2000academic.oup.com
Abstract Spinocerebellar ataxia type 2 (SCA2) is an autosomal dominant disorder caused by
the expansion of a polymorphic (CAG) n tract, which is translated into an expanded
polyglutamine tract in the ataxin-2 protein. Although repeat length and age at disease onset
are inversely related,∼ 50% of the age at onset variance in SCA2 remains unexplained.
Other familial factors have been proposed to account for at least part of this remaining
variance in the polyglutamine disorders. The ability of polyglutamine tracts to interact with …
Abstract
Spinocerebellar ataxia type 2 (SCA2) is an autosomal dominant disorder caused by the expansion of a polymorphic (CAG)n tract, which is translated into an expanded polyglutamine tract in the ataxin-2 protein. Although repeat length and age at disease onset are inversely related, 50% of the age at onset variance in SCA2 remains unexplained. Other familial factors have been proposed to account for at least part of this remaining variance in the polyglutamine disorders. The ability of polyglutamine tracts to interact with each other, as well as the presence of intranuclear inclusions in other polyglutamine disorders, led us to hypothesize that other CAG-containing proteins may interact with expanded ataxin-2 and affect the rate of protein accumulation, and thus influence age at onset. To test this hypothesis, we used step-wise multiple linear regression to examine 10 CAG-containing genes for possible influences on SCA2 age at onset. One locus, RAI1, contributed an additional 4.1% of the variance in SCA2 age at onset after accounting for the effect of the SCA2 expanded repeat. This locus was further studied in SCA3/Machado–Joseph disease (MJD), but did not have an effect on SCA3/MJD age at onset. This result implicates RAI1 as a possible contributor to SCA2 neurodegeneration and raises the possibility that other CAG-containing proteins may play a role in the pathogenesis of other polyglutamine disorders.
Oxford University Press